Announcement on Serious Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Hunan Nucien Pharmaceutical Co. Ltd. on 6ix
Earlier from Hunan Nucien Pharmaceutical
- Announcement on Receiving Notice of Litigation Filing from China Securities Regulatory Commission
- Announcement on Progress in Planning Major Asset Restructuring
- Announcement on Shareholding Reduction Plan for Shareholders
- Announcement on Resolutions of the 16th Meeting of the 2nd Board of Supervisors
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing
Later from Hunan Nucien Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Early Returning of Raised Funds Temporarily Used for Supplementing Current Capital
- Report for Q3 2025
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
Follow Hunan Nucien Pharmaceutical into a list and get an email when it puts out news.
Follow Hunan Nucien Pharmaceutical